Categories
Business

Gene Therapy For Combined Immune Deficiency Market Expectation Surges with Rising Demand and Changing Trends

A formation of group of inherited immune disorders in which lymphocyte functions are impaired and lymphocyte numbers may be diminished is called Combined immune deficiencies (CIDs).These disorders affect the T-cells which disturbs their ability to provide assistance in production of antibodies and therefore causing decreased immunoglobulins. Combined immune deficiency (CID) as a result of defects caused by the gene mutations in the immune system.

The Covid-19 has a positive impact on the Combined Immune Deficiency (CID) Market. The patients with immune deficiency disorders are more prone to developing infectious diseases. The Covid-19 virus has a significant impact on the immune system leading to rising no. of patients with immune deficiency disorders seek consistent treatment.

 Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=5276

Combined Immune Deficiency (CID) Market: Drivers and Restraints

The prevalence of immunodeficiency diseases is on a rise across the globe. According to a study conducted by American academy of pediatrics, the calculated prevalence of diagnosed primary immune deficiency was 1 in 2000 children and 1 in 600 households. This rise in research and development activities that focus on identifying the gene that could cause combined immune deficiency are expected to accelerate new drug development and gene-sequencing. This is expected to drive the growth of the Combined Immune Deficiency (CID) Market.

Combined Immune Deficiency (CID) Market: Segmentation

Tentatively, the global Combined Immune Deficiency (CID) Market has been segmented on the basis of disease type, therapy type and end user.

Based on disease type, the global Combined Immune Deficiency (CID) Market is segmented as:

  • Antibody Deficiency
  • Cellular Immunodeficiency
  • Innate Immune Disorders

Based on therapy type, the global Combined Immune Deficiency (CID) Market is segmented as:

  • Immunoglobulin Replacement Therapy
  • Bone marrow transplant
  • Stem cell transplant
  • Lung transplant
  • Gene therapy
  • Others

Request For Customization – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5276

Based on end user, the global Combined Immune Deficiency (CID) Market is segmented as:

  • Hospitals
  • Ambulatory surgical care
  • Research and development institutes

Combined Immune Deficiency (CID) Market: Overview

Combined Immune Deficiency (CID) Market is expected to witness substantial growth as a result of increasing incidence of Combined Immune Deficiency globally during the forecast period.

Based on therapy type, the gene therapy is expected to dominate the Combined Immune Deficiency (CID) Market during the forecast period. The promising results of recent clinical trials is expected to make gene therapy prominent in the treatment of combined immune deficiency

In the end user segment, the hospitals are expected to hold the largest share in the Combined Immune Deficiency (CID) Market. However, the rigorous research and development activities and the increased focus of the government to encounter immune deficiency disorders is expected to lead considerable growth in the research and development segment.

Combined Immune Deficiency (CID) Market: Key players

Some of the players identified in the Combined Immune Deficiency (CID) Market include:

  • LFB SA
  • Shire plc
  • Kedrion Biopharma Inc
  • CSL Behring
  • Octapharma
  • China Biologic Products Holdings, Inc
  • Sanquin,
  • Grifols, S.A
  • Biotest AG,
  • Baxter International Inc.

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Business

Silicone Aortic Cannula Systems Market Reflect a Holistic Expansion During 2021-2031

The Aortic Cannula Systems is a tube inserted into the aorta during the cardiac surgery and bypass opening of aorta lumen. The aortic cannula systems is minimally invasive, inserted with small incisions and rapid post-surgery recovery. According to the Centre for Disease Control and Prevention (CDC), aortic aneurysm has claimed 9,923 lives in 2018. The aortic cannula systems can be composed of rigid materials such as metals or elastic such as silicone or plastic.

Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=5274

Aortic cannula systems offers minimally invasive treatment with least risk of back-bleeding and effective insertion in the aorta. The global aortic cannula systems market is anticipated to grow steadily in coming years, with the surging cardiac complications and surgeries, advancing medical technology, research and healthcare infrastructure and increasing awareness. Coronavirus pandemic has jolted global aortic cannula systems market due to the lockdown and massive shift towards the coronavirus research and treatment development to cope with the massive influx of infections and death tolls.

The surging prevalence of cardiac disease and surgeries, medical technology and research advancements, healthcare infrastructure and expenditure are driving the growth of the Aortic cannula systems market. The expanding geriatric populations and cardiac diseases are driven by the faulty lifestyle and food habits are fueling the aortic cannula systems market growth. The major player is working with the deliberated effort to equip some novel features into the aortic cannula systems, the advanced feature of the aortic cannula systems allow safe insertion and reduced chances of back-bleed increases its adoptions.

Enquire Before Buying  – https://www.factmr.com/connectus/sample?flag=EB&rep_id=5274

The global aortic cannula systems market is segmented into product, application, end-user and regions.

By product, the global aortic cannula systems market is further segmented into:

  • Plastic (PVC) Cannulas
  • Silicone Cannulas
  • Metal Cannulas (Stainless Steel)

By application, the global aortic cannula systems market is further segmented into:

  • Thoracic Aortic Disease
  • Surgical management of burn injuries
  • Cardiac mechanical support
  • Arterial Venous Cannulation
  • Cardiopulmonary Bypass

By end-user, the global aortic cannula systems market is further segmented into:

  • Hospital
  • Ambulatory Surgery Centers (ASCs)
  • Others

The key players of the global aortic cannula systems market include Cardinal Health, Edwards Lifesciences Corporation, Medidex, LivaNova PLC, CardioMed Supplies Inc., Braile Biomédica and others.

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Business

Drugs For Treatment Of Rare Diseases Propel Demand Of Andersen-Tawil Syndrome Market

In its recently added report by Fact.MR has provided unique insights about Andersen-Tawil Syndrome Market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer the latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments.

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with a detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.

Introduction

Andersen-Tawil syndrome is considered a rare form of periodic paralysis and is a type of long QT syndrome. The Andersen- tawil syndrome leads to changes in heart rhythm (arrhythmia). Episodes of muscle weakness and developmental abnormalities is also observed in patients with Andersen-tawil syndrome.

Head, face, and limbs are primarily affected in the physical abnormalities associated with this condition. Andersen-Tawil syndrome is caused by mutations in the KCNJ2 gene in some cases.

While in other cases, the associated gene is unknown. The KCNJ2 gene mutation can be inherited in an autosomal dominant manner and occur randomly for unknown reasons (sporadically).

It is estimated that the patients suffering from diseases such as diabetes and cardiovascular diseases are at a higher risk to develop andersen-tawil syndrome. Therefore, the rise in prevalence of these diseases may also lead a rise in the number Andersen-Tawil Syndrome cases.

REQUEST A FREE DEMO OF REPORT- https://www.factmr.com/connectus/sample?flag=B&rep_id=5273

Research Coverage

This report segments the functional proteins market based on type, source, form, application and region. In terms of insights, this research report focuses on various levels of analyses—competitive landscape, pricing insights, end-use analysis, and company profiles—which together comprise and discuss the basic views on the emerging & high-growth segments of the functional proteins market, high-growth regions, countries, industry trends, drivers, restraints, opportunities, and challenges.

Critical insights enclosed in the report:

    • In-depth assessment of the leading market players in the Andersen-Tawil Syndrome market
    • The regional analysis of the different market segments and sub-segments
    • Recent mergers, acquisitions, collaborations, partnerships, and R&D activities.
  • SWOT analysis of the prominent players in the Andersen-Tawil Syndrome market
  • Y-o-Y revenue growth of the Andersen-Tawil Syndrome market during the forecast period

Andersen-Tawil Syndrome Market: Key players

Some of the players identified in the Andersen-Tawil Syndrome Market include:

  • Teva Pharmaceuticals Ltd.
  • Zydus Pharmaceuticals, Inc.
  • Sun Pharmaceuticals Industries Ltd.
  • Advanz Pharmaceticals
  • Novartis AG
  • Mylan N.V.

Andersen-Tawil Syndrome Market market: segmented

Tentatively, the global Andersen-Tawil Syndrome Market has been segmented on the basis of disease type, drug-class and distribution channel.

Based on disease type, the global Andersen-Tawil Syndrome Market is segmented as:

  • Type 1
  • Type 2

Based on Drug-class, the global Andersen-Tawil Syndrome Market is segmented as:

  • Carbonic anhydrate Inhibitors
  • Acetazolamide
  • Dichlorpenamide
  • Antiarrhythmic drugs
  • Amiodarone
  • Flecainide
  • Beta-Blockers
  • Atenolol

Based on distribution channel, the global Andersen-Tawil Syndrome Market is segmented as:

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

Reasons to buy this report

  • To get a comprehensive overview of the Andersen-Tawil Syndrome market
  • To gain wide-ranging information about the top players in this industry, their product portfolio details, and the key strategies adopted by them
  • To gain insights about the major countries/regions, in which the Andersen-Tawil Syndrome market is flourishing

REQUEST FOR CUSTOMIZATION – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5273

Andersen-Tawil Syndrome Market: OverviewBased on disease type, type 1 Anderson-Tawil syndrome is expected to hold a larger share in the Anderson-tawil market. As type 1 is caused by a known KCNJ2 gene mutation making it easier to identify and commence the treatment of the disease.In the drug class segment, carbonic anhydrate inhibitors and beta blockers are expected to dominate the Anderson-tawil syndrome market during the forecast period.

Andersen-Tawil Syndrome Market: Regional-Wise OutlookGeographically, the Andersen-Tawil Syndrome Market is segmented into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania and Middle East and Africa.North America is expected to dominate the market owing to high healthcare expenditure. The availability of state of the art healthcare facilities in this region is also expected to drive the growth of the Andersen-Tawil Syndrome Market. The availability of funds for research and government support are factor that makes Europe the second largest market for Andersen-Tawil Syndrome.

South Asia is expected to experience fastest growth in the Andersen-Tawil Syndrome market. This is due to improving healthcare infrastructure along with a rise in the no. of cases suffering from the disease.

In addition, rising awareness may also help to drive the growth of the Andersen-Tawil Syndrome market at a faster rate in this region. The developing private healthcare in countries like India may also lead to contributing towards the growth of Andersen-Tawil Syndrome market.

However, limited technological advancement, slow economic growth and absence of major players in the Middle East and Africa will lead to limited growth of Andersen-Tawil Syndrome Market in this region.

Why Purchase From Fact.MR?

  • Customized market reports as per the clients’ requirement
  • Rich experience in curating market reports for clients from different industrial domains
  • Round the clock customer service for clients in different time zones
  • Over 300+ queries addressed every day
  • Catering to over 700+ clients each year

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Smart Pulse Oximeters Market: Awareness Drives for Treatment of COPD and Asthma Remains USP

Continuous technological advancements and introduction of efficient pulse oximeters are the key driving factors for pulse oximeters market growth. The global sales of pulse oximeters were estimated at US$ 1.2 Bn in 2019, and projected to witness moderate growth during the forecast period (2019 – 2029).

“Technological advancements leading to the introduction of new and advanced products and emergence of number of players in the market have intensified pulse oximeter sales,” says a Fact.MR analyst.    

In January 2017, Masimo launched two patient monitoring products in India namely, Rad-97 Pulse-CO Oximeter and SedLine Brain Function Monitoring. These products are expected to improve the patient monitoring capabilities of clinicians. Moreover, government-driven price management and reimbursement controls, particularly in China and Japan, are offering significant opportunities for manufacturers to invest in these regions. Increasing government initiatives to spread awareness related to various respiratory diseases are boosting the sales of pulse oximeter devices.

For detailed insights on enhancing your product footprint, request a sample here-
https://www.factmr.com/connectus/sample?flag=S&rep_id=4449

Key Takeaways of Pulse Oximeter Market Study

  • A large number of companies manufacturing handheld pulse oximeters significantly contributed to the market share in terms of revenue in the pulse oximeters market.
  • North America and Europe collectively hold over 60% of the pulse oximeters market share owing to rapid new product launches in these regions.
  • In terms of end user, hospitals are expected to dominate the pulse oximeters market during the forecast period.
  • The pulse oximeter market is highly fragmented. Some of the prominent manufacturers include Masimo Corp, Medtronic plc., Koninklijke Philips NV, GE Healthcare, Rossmax International Ltd. and few others.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4449

Key Segments of Pulse oximeters Market

Fact.MR’s study on the pulse oximeters market offers information divided into three important segments – product type, end user and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type
  • Finger Pulse Oximeters
  • Hand Held Pulse Oximeters
  • Table Top Pulse Oximeters
  • Wrist Pulse Oximeters
End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Homecare Settings
Region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4449

Awareness Drives for Treatment of COPD and Asthma Remains USP

Several awareness programs have been introduced and promoted by various health organizations or healthcare societies such as online education programs for healthcare professionals, medication maintenance programs and environmental programs, across the globe to control respiratory disorders such as asthma, COPD and other respiratory disease. The introduction and promotion of various awareness programs are expected to increase the growth of pulse oximeters market. These government programs encourage people to adopt early medication, which is expected to increase the revenue generation for the global pulse oximeters market in the forecast years.

pulse oximeters market 2

Looking for More Information?

The research study on pulse oximeter market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of pulse oximeter over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence over 2019 – 2029. Market statistics have been presented on the basis of product type (finger pulse oximeters, hand held pulse oximeters, table top pulse oximeters and wrist pulse oximeter), and end user (hospitals, clinics, ambulatory surgical centers and homecare settings) across seven major regions.

Explore More Trending Reports of Fact.MR

Pelvic Floor Stimulator Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/pelvic-floor-stimulator-market )

Terminal Sterilization Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/terminal-sterilization-market )

Cardiac Patch Monitor Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031 (https://www.factmr.com/report/cardiac-patch-monitor-market  )

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Increase In R&D Spending In The Pharmaceutical Industry Opens Up The New Avenues for Cytokines Drugs : Report Fact.MR

Self-administered drugs through pre-filled syringes offer opportunities to reduce consumer spending on caregiver fees. Furthermore, manufacturers are gaining sharper profit margins with the introduction of this drug delivery medium in their portfolio. On this backdrop, the global demand for parenteral drugs was estimated at US$ 451 Bn in 2019, is projected to witness moderate growth during the forecast period (2019 – 2029). Parenteral drug manufactures are currently focused on maintaining high quality of their products.

For detailed insights on enhancing your product footprint, request for a sample here- 
https://www.factmr.com/connectus/sample?flag=S&rep_id=3189

Drugs for cancer are always short in supply in countries where the market is monopolistic and access to such medicines is dominated by a single player. Rising prevalence of chronic illnesses such as cancer, cardiovascular diseases, and diabetes, across the globe has been the prime revenue driver for parenteral drugs and this trend is not likely to abate any time in the foreseeable future.

Key Takeaways of Parenteral Drugs Market Study

  • By product type, monoclonal antibodies segment accounts for maximum market share in terms of revenue in the parenteral drugs market. This is primarily attributed to the rising adoption of biologics and subsequent rise in the number of biologics approved for marketing.
  • North America and Europe collectively hold over 60% of the parenteral drugs market share owing to the rise in new product launches in the regions.
  • Hospital pharmacies segment is expected to be the dominant distribution channel in the parenteral drugs market.
  • The parenteral drugs market is highly fragmented. Some of the prominent parenteral drug manufacturers include, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis AG, and Pfizer Inc., among many others.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=3189

“Patent expiration of branded products and fewer new product launches have resulted in the rise of generic versions of drugs, and in the emergence of a number of players in the market – this factor has intensified total parenteral drugs sales,” says a Fact.MR analyst.

parenteral drugs market 03

Key Segments of Parenteral Drugs Market

Fact.MR’s study on the parenteral drugs market offers information divided into six important segments— product type, application, molecule type, route of administration, distribution channel, and region.

This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type
  • Monoclonal Antibodies
  • Immunoglobulin
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Blood Factors
  • Peptide Antibiotics
  • Vaccines
  • Small Molecule Antibiotics
  • Chemotherapy Agents
  • Others
Application
  • Oncology
  • Infectious Diseases
  • Diabetes
  • Blood disorders
  • Hormonal Disorders
  • Musculoskeletal Disorders
  • CNS Diseases
  • Pain Management
  • Cardiovascular Diseases
Molecule Type
  • Small Molecules
  • Large Molecules
Route of Administration
  • Intravenous (IV)
  • Intramuscular (IM)
  • Subcutaneous (SC)
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
Region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/3189

Increased Research Funding to Drive Parenteral Drugs Market Growth

Research funding has surged significantly in recent years, which has resulted in an increase in the number of projects undertaken as well as newly employed personnel for the same. The funding for research comes from governments, private players, and other commercial entities. For instance,

  • In 2017, the National Cancer Institute (NCI) received over US$ 5.6 billion for research initiatives, which reflects a 7% increase as compared to 2016.
  • Similarly, in 2018, in the U.S., the Omnibus Appropriations bill that provided additional funding of US$ 3 billion for the NIH (National Institutes of Health) was passed, which is the highest increase in NIH funding in the past 15 years. This boost in funding, which brings the total NIH investment to US$ 37.1 billion for FY 2018, is expected to speed up cancer research in the coming years.
  • The expected trend indicates a significant rise in NIH funding in the fiscal year 2017 – 2018. In the future, investments in R&D are likely to increase in all countries across the world, especially in countries such as China and Brazil.

Explore More Trending Reports of Fact.MR

Pelvic Floor Stimulator Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/pelvic-floor-stimulator-market )

Terminal Sterilization Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/terminal-sterilization-market )

Cardiac Patch Monitor Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031 (https://www.factmr.com/report/cardiac-patch-monitor-market  )

 

Looking for More Information?

The research study on parenteral drugs market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of parenteral drugs over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence over 2019 – 2029. Market statistics have been presented on the basis of product type (monoclonal antibodies, immunoglobulin, cytokines, indulin, peptide harmones, blood factors, peptide antibiotics, vaccines, small molecule antibiotics, chemotherapy agents, and others), application (oncology, infectious diseases, diabetes, hormonal disorders, musculoskeletal disorders, CNS diseases, pain management and cardiovascular diseases), route of administration (intravenous, intramuscular and subcutaneous), and distribution channel (hospital pharmacies, retail pharmacies, drug stores and online pharmacies) across seven major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Sales of Alprazolam Medicine Is Expected to Record a CAGR of Around 2.7% Over the Forcast Period

The demand for benzodiazepine drugs is expected to record a pedestrian CAGR of around 2.7% during the forecast period (2020-2026). The U.S. is expected to account for around one-third of the total share in the global benzodiazepine drugs market by 2026. Growing prevalence of anxiety in parallel with rising awareness regarding benzodiazepine drugs is reflecting on increasing opportunities for players in the U.S. market. As per a report by the Anxiety and Depression Association of America (ADAA), each year, over 40 Mn adults in the U.S. suffer from anxiety disorders.

A comprehensive study by Fact.MR opines that demand for benzodiazepine drugs would remain high-albeit generic ones-which would drive voluminous sales, though contribute moderately to market value.

For detailed insights on enhancing your product footprint, request for a sample here- 

https://www.factmr.com/connectus/sample?flag=S&rep_id=4432

Presence of a large number of hospital and retail pharmacies further makes it easy for individuals to purchase benzodiazepine drugs. A significant influence of high concentration of leading players is also auguring well for the U.S. benzodiazepine drugs market, which has been discussed in detail, in a recent Fact.MR study.

A subject matter expert at Fact.MR opines, “Regulations regarding development of benzodiazepine drugs are relatively stringent in developed regions such as North America and Europe, which opens ground for branded as well as generic drugs in developing regions. As a result, entry barriers in developed regions would be high, while those in developing regions would be moderate.”

analysis of benzodiazepine drugs market by application

Key Highlights of Benzodiazepine Drugs Market Study

  • Easy accessibility is a key feature driving substantial sales of benzodiazepine drugs through retail pharmacies. By 2026, these pharmacies are projected to record value tantamount to US$ 1.4 Bn. Additionally, sales prospects for benzodiazepine drugs are likely to grow during the forecast period, as consumers are evincing high interest in online pharmacies.
  • Popularity of short-acting benzodiazepine drugs is expected to increase during the forecast period, as these induce less hangover effect and take relatively short time of action. On the back of this, around 77% of the total share would be attributable to the sales of short-acting benzodiazepine drugs.
  • Being a highly prevalent disorder among individuals leading a demanding lifestyle, anxiety is projected to account for a sizeable share tantamount to around 53% in the benzodiazepine drugs market during the forecast period.
  • Reduction in the number of prescriptions for benzodiazepine drugs, especially in countries such as the U.S., the U.K., and Canada, would impede market growth during the forecast period.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4432

Benzodiazepine Drugs Market – Assessment of Key Segments

Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Time of Action
  • Ultra-short Acting
  • Short Acting
  • Long Acting
Application
  • Anxiety
  • Seizures
  • Insomnia
  • Alcohol Withdrawal
  • Others
Product
  • Alprazolam
  • Clonazepam
  • Diazepam
  • Lorazepam
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4432

High Popularity of Generic Drugs Puts Pressure on Branded Products of Leading Players

The benzodiazepine drugs market features fragmentation, as leading players operate under the constant pressure of patent expiration of branded products. High investments made towards the development of innovative and new products by leading players intensifies pressure to achieve the desired RoI. For instance, in 2017, F.Hoffmann-La Roche AG invested around one-fifth of the total revenue to strengthen the pipeline of innovative products. Stringent regulations on innovative drugs further make it difficult for leading players to gain desired marketability.

On the other side, the focus of prominent and leading players is on achieving better penetration into the benzodiazepine drugs market through the development of generic drugs. Growing sales of generic benzodiazepine drugs are putting pressure on leading players to squeeze their profit margins and adopt a cost-competitive strategy to have better sales prospects.

Find More Valuable Insights on Benzodiazepine Drugs Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global benzodiazepine drugs market, presenting historical demand data (2016-2019), and forecast statistics for the period of 2020-2026. The study divulges compelling insights on the benzodiazepine drugs market on the basis of distribution channel (hospital pharmacies, retail pharmacies, and others), time of action (ultra-short acting, short acting, and long acting), application (anxiety, seizures, insomnia, alcohol withdrawal, and others), and product (alprazolam, clonazepam, diazepam, lorazepam, and others), across five major regions.

Explore More Trending Reports of Fact.MR

Pelvic Floor Stimulator Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/pelvic-floor-stimulator-market )

Terminal Sterilization Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/terminal-sterilization-market )

Cardiac Patch Monitor Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031 (https://www.factmr.com/report/cardiac-patch-monitor-market  )

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Content Source: https://www.factmr.com/media-release/1212/benzodiazepine-drugs-demand

Categories
Pharmaceutical

North America Imipenem Based Antibiotics Is Expected to Offer Substantial Revenue Generation Opportunities Says Fact.MR

Incidence of bacterial infections with multidrug resistance is increasing rapidly, generating the need for novel, broad-spectrum carbapenem-based antibiotics for the treatment of various bacterial infections. Broad-spectrum carbapenem-based antibiotics such as tebipenem (Spero Therapeutics Inc.) and sulopenem (Iterum Therapeutics Inc.) are at late stage clinical development with expected launch of both in 2020 – 2021. Incidence of bacterial infections is increasing rapidly across the world offering significant revenue generating opportunities for the carbapenem-based antibiotics market.

Multidrug resistance to currently marketed carbapenem-based antibiotics is largely prevalent in the world. Also, expiry of patent for ertapenem is expected to offer new avenues for market growth in regulated as well as non-regulated carbapenem-based antibiotics market where its adoption & availability are comparatively limited. On the back of these factors, the global sales of carbapenem-based antibiotics is estimated to reach a valuation of US$1.8 Bn by 2029.

For detailed insights on enhancing your product footprint, request for a sample here- 

https://www.factmr.com/connectus/sample?flag=S&rep_id=4425

“ Recently, FDA granted Qualified Infectious Disease Product (QIDP) to sulopenem as well as tebipenem for new indications, which is further expected to broaden the growth prospect of the carbapenem-based antibiotics market,” says the Fact.MR Analyst.

Key Takeaways of Carbapenem-based Antibiotics Market Study

  • Larger patient pools and launch of novel products for the treatment of bacterial infections are expected to shape the carbapenem-based antibiotics market landscape.
  • Increasing prevalence of bacterial infections caused by longer stay in hospitals as well as immunocompromising chronic diseases that make patients prone to bacterial infections is expected to boost carbapenem-based antibiotics market growth.
  • Currently, the carbapenem-based antibiotics market is dominated by ertapenem. However, tebipenem is expected to gain traction during the forecast period in terms of revenue.
  • In terms of indication, pneumonia is expected to garner highest market share as compared to other bacterial infections owing to a large patient pool.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4425]

Fact.MR’s study on the carbapenem-based antibiotics therapy market offers information divided into four important segments – product, indication, sales channel, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.

Key Segments of Carbapenem-based Antibiotics Market

Product Type
  • Meropenem
  • Ertapenem
  • Imipenem
  • Doripenem
  • Panipenem
  • Tebipenem
Indication
  • Intra-abdominal Infections
  • Urinary Tract Infections
  • Pneumonia
  • Bacterial Meningitis
  • Skin and Skin Structure Infections
  • Acute Pelvic Infections
  • Prophylaxis of Surgical Site Infection
  • Respiratory Tract Infections
  • Gynaecologic Infections
  • Endocarditis
  • Others
Sales Channel
  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Online Pharmacies
Region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Strategic Expansion by Dominant Players Benefiting Market

The carbapenem-based antibiotics market is dominated by top three players including Merck Co. & Inc., Pfizer Inc., and Sumitomo Dainippon Pharma Co., Ltd. These leading players in the carbapenem-based antibiotics market contribute around 80% to 90% revenue share. Clinical stage companies such as Spero Therapeutic Inc. and Iterum Therapeutics Inc. with the launch of their novel carbapenem-based antibiotics are expected to acquire significant market space. In October 2017, Spero Therapeutics, Inc. and Meiji Seika Pharma Co., Ltd. announced an exclusive licensed partnership for its carbapenem-based antibiotic named SPR994 (tebipenem). In a similar development, Sumitomo Dainippon Pharma in June 2017, announced a partnership with Zuellig Pharma for sales of carbapenem-based antibiotic meropenem in five countries of Southeast Asia (Vietnam, Thailand, Singapore, Philippines, Malaysia) and Hong Kong.

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4425

carbapenem based antibiotics market 01

Key Questions Answered in Fact.MR’s Carbapenem-based Antibiotics Market Report

  • Which regions will continue to remain the most profitable regional markets for carbapenem-based antibiotics market players?
  • Which factors will essentially induce a change in the demand for carbapenem-based antibiotics in the forecast period?
  • How will changing trends impact the carbapenem-based antibiotics market?
  • What are key manufacturers’ strategy to enhance their product adoption and improve regional product footprints?
  • Which companies are leading the carbapenem-based antibiotics market?

For More Insights
https://www.biospace.com/article/epidermal-cell-sheets-sales-surges-due-to-growing-need-for-effective-and-safe-guiding-technology-says-fact-mr/

Looking for more information?

The research study on carbapenem-based antibiotics market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends which have shaped the landscape of carbapenem-based antibiotics over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence over 2019 – 2029. Market statistics have been presented on the basis of product type (Meropenem, imipenem, ertapenem, tebipenem, doripenem, panipenem, etc.), indication (intra-abdominal infections, urinary tract infections, pneumonia, bacterial meningitis, skin and skin structure infections, acute pelvic infections, prophylaxis of surgical site infection, respiratory tract infections, others), sales channel (hospital pharmacies, retail pharmacies, online pharmacies) across seven major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

  • Tags
Categories
Pharmaceutical

Custom Foot Orthotic Insoles Continue to Account for Greater Revenue Share Owing to the Clinically Proven Benefits : Report Fact.MR

Factors such as obesity, and changing lifestyle are fueling the prominence of bone-related disorders including, osteoarthritis, rheumatoid arthritis, and juvenile arthritis. Sudden collapses due to weakened sensory capabilities of the foot are the primary reason of injuries among the geriatric cohort. The same is applicable for individuals having diabetes.

Foot orthotic insoles are beneficial in foot alignment, or unload points of pain and pressure. As per the Fact.MR’s study, the worldwide sales of foot orthotic insoles will surpass US$ 4 Bn in 2026. Technological advancements, spurred by upsurge in R&D projects, are expected to remain critical in shaping market growth in the coming years. Notable shift towards online sales channels would further boost value creation.

For detailed insights on enhancing your product footprint, request a sample here- 

https://www.factmr.com/connectus/sample?flag=S&rep_id=4666

Key Segments Covered of the Foot Orthotic Insoles Market

  • Product
    • Prefabricated
    • Custom
      • Rigid/Function Orthotic Insoles
      • Soft/Accommodative Insoles
  • Age Group
    • Adult
    • Pediatric
  • Application
    • Sports & Athletics
    • Medical
    • Personal Comfort
  • Material
    • Thermoplastics
    • Polyethylene Foams
    • Leather
    • Cork
    • Composite Carbon Fibers
    • EVA
    • Gel
    • Others
  • End User
    • Prefabricated
      • Adult
      • Pediatric
    • Custom
      • Adult
      • Pediatric
  • Distribution Channel
    • Drug Stores
    • Hospitals & Specialty Clinics
    • Online Stores
    • Others
  • Region
    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia
    • Oceania
    • Middle East & Africa (MEA)

Speak to Research Analyst
https://www.factmr.com/connectus/sample?flag=AE&rep_id=4666

foot orthotic insoles market 2

Key Takeaways of Foot Orthotic Insoles Market

  • Custom foot orthotic insoles continue to account for greater revenue share as they possess clinically proven benefits over prefabricated products.
  • Adults are set to be the primary customers of foot orthotic insoles, capturing around 70% of total market value; adoption among pediatrics to slide gradually.
  • Rise in caseloads of diseases – diabetes, foot ulcers, and arthritis – is fueling the application of foot orthotic insoles for medical purposes.
  • Hospitals & specialty clinics translate to greater sales of foot orthotic insoles, owing to presence of skilled professionals and proper healthcare infrastructure.
  • North America would continue its hegemony, attributable to tech-driven advancements in healthcare industry, and conducive government policies; APAC’s market to emerge as fastest-growing.

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4666

“Manufacturers are exploring new substrates such as thermoplastics and carbon composite fibers to develop foot orthotic insoles. Further, they are employing innovative technologies including, 3D bioprinting, and computer-aided fixation of foot orthotic insoles, as they offer benefits of decreased complications, and better shelf life”, says Fact.MR analyst.

Manufacturers to Target Custom Foot Orthotics Insoles for Better Margins

As the healthcare sector undergoes tech-enabled transformations, customers are expecting a greater level of customization in foot orthotic insoles. Custom foot orthotics insoles are specifically designed to fit perfectly to the feet of the customers, providing support and comfort. They are manufactured after a thorough evaluation of the foot structure of the customer.

Custom foot orthotic insoles are effective in relieving conditions such as lower back pain, leg fatigue, heel pain/plantar facilities, and other foot conditions associated with diseases including, diabetes and arthritis. For instance, according to PLOS ONE, custom- made foot orthotic insoles decrease tibial and head acceleration rates versus the prefabricated variant.

Market players putting greater emphasis on product customization will be well placed to significantly increase margins, revenue, and profit.

Explore More Trending Reports of Fact.MR

Pelvic Floor Stimulator Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/pelvic-floor-stimulator-market )

Terminal Sterilization Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/terminal-sterilization-market )

Cardiac Patch Monitor Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031 (https://www.factmr.com/report/cardiac-patch-monitor-market  )

Looking for More Valuable Insights?

Fact.MR, in its recent study, offers an extensive analysis of the foot orthotic insoles market, offering historical demand data and projection figures for the period, 2020-2026. The study highlights key insights on foot orthotic insoles on the basis of product (Prefabricated, and Custom), user age group (Adult, and Pediatric), application (Sports & Athletics, Medical, and Personal Comfort), distribution channel (Drug Stores, Hospitals& Specialty Clinics, Online Stores, and others) and across key regions (North America, Europe, Asia Pacific (APAC), Latin America, and Middle East & Africa (MEA)).

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.comContent Source: https://www.factmr.com/media-release/1420/global-foot-orthotic-insoles-market

Categories
Pharmaceutical

Sales of Blood Collection Tubes for Liquid Biopsy to Soar at 6% CAGR Through 2029; Opportunities Abound in Genetic Diagnostics, Says Fact.MR

Blood Collection Tubes for Liquid Biopsy Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations  for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Blood Collection Tubes for Liquid Biopsy insightful data for the specific country/regions.

The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Blood Collection Tubes for Liquid Biopsy market and quantified with insightful rationale.

The Demand analysis of Blood Collection Tubes for Liquid Biopsy Market offers a comprehensive analysis of diverse features, demand, product developments, revenue generation, and sales of Blood Collection Tubes for Liquid Biopsy Market across the globe.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=4495

Key Segments of the Blood Collection Tubes for Liquid Biopsy Market

Market by Category

  • Product

    • ccfDNA Tubes
    • ccfDNA Isolation Kits
    • cfRNA Tubes
    • ccfRNA Isolation Kits
    • CTC Tubes
    • gDNA Tubes
    • gDNA Isolation Kits
    • Intracellular RNA Tubes
    • Intracellular RNA Kits
    • NIPT

  • Material

    • Glass
    • Plastic

  • Application

    • IVD
    • Research

  •  End User

    • R&D centres
    • Genetic Diagnostic Labs
    • Conventional Diagnostic Centres

  • Region

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia
    • Oceania
    • MEA

A comprehensive estimate of the Blood Collection Tubes for Liquid Biopsy market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the Sales of Blood Collection Tubes for Liquid Biopsy during the forecast period. Price point comparison by region with the global average price is also considered in the study.

The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the Market Insights of Blood Collection Tubes for Liquid Biopsy.

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=4495

Some Notable Offerings by Fact.MR Report on Blood Collection Tubes for Liquid Biopsy market:

  • We will provide you an analysis of the extent to which this Blood Collection Tubes for Liquid Biopsy market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
  • We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
  • Also, this report will help you to identify any trends to forecast growth rates.
  • The analyzed report will forecast the general tendency for supply and demand.

Some of the Blood Collection Tubes for Liquid Biopsy Market insights and estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides: 

  • Details regarding latest innovations and development in Blood Collection Tubes for Liquid Biopsy and how it is gaining customer traction during the forecast period.
  • Analysis about the customer demand of the products and how it is likely to evolve in coming years.
  • Latest regulations enforced by government bodies and local agencies and their impact on Demand of Blood Collection Tubes for Liquid Biopsy Market .
  • Insights about adoption of new technologies and its influence on the Blood Collection Tubes for Liquid Biopsy market Size.
  • Overview of the impact of COVID-19 on Blood Collection Tubes for Liquid Biopsy Market and economic disruptions caused by the pandemic.
  • Evaluates post-pandemic impact on the Sales of Blood Collection Tubes for Liquid Biopsy Market during the forecast period.

To get all-in insights on the regional landscape of the Blood Collection Tubes for Liquid Biopsy Market, Buy Now:-https://www.factmr.com/checkout/4495

Key stakeholders in Market including industry players, policymakers, and investors in various countries have been continuously realigning their strategies and approaches to implement them in order to tap into new opportunities.

Key Takeaways – Blood Collection Tubes for Liquid Biopsy

  • Healthcare centers would show remarkable growth in adoption of blood collection tubes for liquid biopsy owing to the rise in number of research activities.
  • Increasing prevalence of cancers will remain one of the major factors responsible for the growth of the blood collection tubes for liquid biopsy market.
  • Blood collection tubes for liquid biopsy market is a fragmented landscape.
  • Growing demand for single needle penetration for multiple tests is identified as the key growth engine, pushing adoption of blood collection tubes for liquid biopsy.

After reading the Market insights of Blood Collection Tubes for Liquid Biopsy Report, readers can:

  • Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
  • Analyze key regions holding significant share of total Blood Collection Tubes for Liquid Biopsy market revenue.
  • Study the growth outlook of Blood Collection Tubes for Liquid Biopsy market scenario, including production, consumption, history and forecast.
  • Learn consumption pattern and impact of each end use & supply side analysis of Blood Collection Tubes for Liquid Biopsy market.
  • Investigate the recent R&D projects performed by each market player & competitive analysis of Blood Collection Tubes for Liquid Biopsy Market Players.

Read More Trending Reports of Fact.MR: –https://www.biospace.com/article/aseptic-transfer-system-market-to-grow-at-6-5-percent-cagr-high-demand-for-liquid-transfer-system-boosts-growth-fact-mr/

How Fact.MR Assists in Making Strategic Moves For Blood Collection Tubes for Liquid Biopsy Market Manufacturer?

  • The data provided in the Blood Collection Tubes for Liquid Biopsy market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
  • The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

 More Related Reports by Fact.MR On Healthcare Sector: 

Veterinary Endodontics Market :_Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Therapeutic Support Surface Market:- Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Computer-Assisted Orthopedic Surgery Market :-Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

 

Categories
Pharmaceutical

Artificial Limbs Market to Expand at a Healthy CAGR of 6% through 2025

Artificial Limbs Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations  for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Artificial Limbs insightful data for the specific country/regions.

The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Artificial Limbs market and quantified with insightful rationale.

The Demand analysis of Artificial Limbs Market offers a comprehensive analysis of diverse features, demand, product developments, revenue generation, and sales of Artificial Limbs Market across the globe.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=4359

Artificial Limbs Market – Assessment of Key Segments

With an aim to offer granular level insights on the artificial limbs market, authors of the report have segmented the landscape on the basis of product, technology, end user, and region. This global research report also analysis the incremental opportunity available in the artificial limbs market during the forecast period. Key segments of the artificial limbs market include:

Product
  • Upper Extremity
  • Lower Extremity
  • Sockets
  • Liners
  • Others
Technology
  • Cosmetic Prosthetics
  • Cable-operated/Battery-powered Prosthetics
  • Electrically-powered/Myoelectric Prosthetics
End User
  • Hospitals
  • Prosthetic Clinics
  • Rehabilitation Centres
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

A comprehensive estimate of the Artificial Limbs market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the Sales of Artificial Limbs during the forecast period. Price point comparison by region with the global average price is also considered in the study.

The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the Market Insights of Artificial Limbs.

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=4359

Some Notable Offerings by Fact.MR Report on Artificial Limbs market:

  • We will provide you an analysis of the extent to which this Artificial Limbs market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
  • We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
  • Also, this report will help you to identify any trends to forecast growth rates.
  • The analyzed report will forecast the general tendency for supply and demand.

Some of the Artificial Limbs Market insights and estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides: 

  • Details regarding latest innovations and development in Artificial Limbs and how it is gaining customer traction during the forecast period.
  • Analysis about the customer demand of the products and how it is likely to evolve in coming years.
  • Latest regulations enforced by government bodies and local agencies and their impact on Demand of Artificial Limbs Market .
  • Insights about adoption of new technologies and its influence on the Artificial Limbs market Size.
  • Overview of the impact of COVID-19 on Artificial Limbs Market and economic disruptions caused by the pandemic.
  • Evaluates post-pandemic impact on the Sales of Artificial Limbs Market during the forecast period.

Key Takeaways of Artificial Limbs Market

  • Lower extremity prosthetics accounted for 55% share of the market in 2019, owing to the high prevalence of diabetes and vascular diseases across the globe.
  • Electrically-powered/myoelectric prosthetics are projected register the fastest growth by the end of the forecast period. Advancements such as multi-articulating myoelectric hands are estimated to fuel this growth.
  • According to Fact.MR, hospitals and prosthetic clinics will collectively account for 75% of the market share by the end of the forecast year. An uptick in the demand for prosthetics for trauma injuries and amputations during military combat will bolster the growth of these segments.
  • North America will lead the artificial limbs market by the end of the forecast period. However, Asia Pacific will witness prolific growth, on the back of a surging geriatric population and an alarming high incidence of accidents.

To get all-in insights on the regional landscape of the Artificial Limbs Market, Buy Now:-https://www.factmr.com/checkout/4359

Key stakeholders in Market including industry players, policymakers, and investors in various countries have been continuously realigning their strategies and approaches to implement them in order to tap into new opportunities.

Key Parameters analyzed while estimating the Artificial Limbs market include:

  • To analyze Drugs/ Therapeutic Area in Artificial Limbs :

Overall Population by age group/Prevalence or Incidence of any disease/Treatment Seeking Rate/Dosage pattern/Average duration of treatment/Overall treatment cost and Reimbursement are considered.

  • To analyze Consumables of Artificial Limbs:

Overall Population/Prevalence or Incidence of disease/treatment seeking rate/ average duration of the treatment/average number of devices used per patient / average number of procedure per device/ average selling price per device/reimbursement are considered.

  • To analyze Artificial Limbs Equipment:

Number of Healthcare facilities (Hospitals/Ambulatory Surgical Centers/Clinics etc.)

Average number of devices installed per facilities/ lifespan of the devices/replacement rate of the equipment/new sales of the equipment per year/average selling price per equipment are considered.

After reading the Market insights of Artificial Limbs Report, readers can:

  • Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
  • Analyze key regions holding significant share of total Artificial Limbs market revenue.
  • Study the growth outlook of Artificial Limbs market scenario, including production, consumption, history and forecast.
  • Learn consumption pattern and impact of each end use & supply side analysis of Artificial Limbs market.
  • Investigate the recent R&D projects performed by each market player & competitive analysis of Artificial Limbs Market Players.

Read More Trending Reports of Fact.MR: –https://www.biospace.com/article/aseptic-transfer-system-market-to-grow-at-6-5-percent-cagr-high-demand-for-liquid-transfer-system-boosts-growth-fact-mr/

How Fact.MR Assists in Making Strategic Moves For Artificial Limbs Market Manufacturer?

  • The data provided in the Artificial Limbs market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
  • The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

 

More Related Reports by Fact.MR On Healthcare Sector: 

Veterinary Endodontics Market :_Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Therapeutic Support Surface Market:- Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Computer-Assisted Orthopedic Surgery Market :-Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com